Bank of Stockton’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-4,306
| Closed | -$232K | – | 136 |
|
|
2025
Q4 | $232K | Sell |
4,306
-930
| -18% | -$44.7K | 0.07% | 129 |
|
|
2025
Q3 | $236K | Sell |
5,236
-292
| -5% | -$13.6K | 0.07% | 132 |
|
|
2025
Q2 | $256K | Sell |
5,528
-250
| -4% | -$12.3K | 0.08% | 125 |
|
|
2025
Q1 | $352K | Buy |
5,778
+34
| +0.6% | +$1.98K | 0.11% | 112 |
|
|
2024
Q4 | $325K | Sell |
5,744
-52
| -0.9% | -$2.9K | 0.1% | 113 |
|
|
2024
Q3 | $300K | Sell |
5,796
-227
| -4% | -$10.6K | 0.09% | 123 |
|
|
2024
Q2 | $250K | Sell |
6,023
-337
| -5% | -$15.1K | 0.08% | 119 |
|
|
2024
Q1 | $345K | Hold |
6,360
| – | – | 0.11% | 104 |
|
|
2023
Q4 | $319K | Sell |
6,360
-70
| -1% | -$3.67K | 0.11% | 105 |
|
|
2023
Q3 | $341K | Sell |
6,430
-778
| -11% | -$47.7K | 0.13% | 84 |
|
|
2023
Q2 | $461K | Buy |
7,208
+447
| +7% | +$30K | 0.16% | 79 |
|
|
2023
Q1 | $469K | Sell |
6,761
-475
| -7% | -$33.5K | 0.16% | 78 |
|
|
2022
Q4 | $521K | Sell |
7,236
-100
| -1% | -$7.54K | 0.18% | 73 |
|
|
2022
Q3 | $522K | Hold |
7,336
| – | – | 0.2% | 73 |
|
|
2022
Q2 | $565K | Hold |
7,336
| – | – | 0.21% | 74 |
|
|
2022
Q1 | $536K | Buy |
7,336
+11
| +0.2% | +$739 | 0.17% | 75 |
|
|
2021
Q4 | $457K | Hold |
7,325
| – | – | 0.13% | 86 |
|
|
2021
Q3 | $433K | Sell |
7,325
-12
| -0.2% | -$790 | 0.13% | 83 |
|
|
2021
Q2 | $490K | Sell |
7,337
-350
| -5% | -$22.8K | 0.15% | 80 |
|
|
2021
Q1 | $485K | Sell |
7,687
-450
| -6% | -$28K | 0.16% | 78 |
|
|
2020
Q4 | $504K | Sell |
8,137
-2,225
| -21% | -$137K | 0.19% | 73 |
|
|
2020
Q3 | $624K | Sell |
10,362
-2,129
| -17% | -$128K | 0.26% | 65 |
|
|
2020
Q2 | $734K | Buy |
12,491
+3,770
| +43% | +$225K | 0.32% | 60 |
|
|
2020
Q1 | $486K | Sell |
8,721
-118
| -1% | -$7.21K | 0.27% | 64 |
|
|
2019
Q4 | $567K | Buy |
8,839
+694
| +9% | +$39.7K | 0.24% | 68 |
|
|
2019
Q3 | $413K | Sell |
8,145
-2,436
| -23% | -$114K | 0.18% | 81 |
|
|
2019
Q2 | $479K | Sell |
10,581
-808
| -7% | -$37.6K | 0.24% | 69 |
|
|
2019
Q1 | $543K | Sell |
11,389
-2,496
| -18% | -$124K | 0.28% | 66 |
|
|
2018
Q4 | $721K | Sell |
13,885
-1,385
| -9% | -$74.4K | 0.44% | 54 |
|
|
2018
Q3 | $947K | Sell |
15,270
-55
| -0.4% | -$3.26K | 0.48% | 49 |
|
|
2018
Q2 | $847K | Sell |
15,325
-1,404
| -8% | -$75.8K | 0.46% | 50 |
|
|
2018
Q1 | $1.06M | Sell |
16,729
-85
| -0.5% | -$5.47K | 0.44% | 46 |
|
|
2017
Q4 | $1.03M | Buy |
16,814
+309
| +2% | +$19.3K | 0.42% | 50 |
|
|
2017
Q3 | $1.05M | Sell |
16,505
-1,195
| -7% | -$69.8K | 0.48% | 45 |
|
|
2017
Q2 | $985K | Sell |
17,700
-265
| -1% | -$14.4K | 0.45% | 45 |
|
|
2017
Q1 | $976K | Sell |
17,965
-3,450
| -16% | -$189K | 0.45% | 45 |
|
|
2016
Q4 | $1.25M | Sell |
21,415
-425
| -2% | -$23.2K | 0.6% | 34 |
|
|
2016
Q3 | $1.18M | Buy |
21,840
+1,100
| +5% | +$70.7K | 0.58% | 36 |
|
|
2016
Q2 | $1.53M | Sell |
20,740
-1,145
| -5% | -$80.9K | 0.81% | 25 |
|
|
2016
Q1 | $1.4M | Buy |
21,885
+1,293
| +6% | +$81.5K | 0.76% | 25 |
|
|
2015
Q4 | $1.42M | Buy |
20,592
+1,200
| +6% | +$79.3K | 0.81% | 26 |
|
|
2015
Q3 | $1.15M | Buy |
19,392
+1,800
| +10% | +$114K | 0.7% | 29 |
|
|
2015
Q2 | $1.17M | Buy |
17,592
+1,645
| +10% | +$108K | 0.65% | 32 |
|
|
2015
Q1 | $1.03M | Buy |
15,947
+317
| +2% | +$19.8K | 0.56% | 38 |
|
|
2014
Q4 | $922K | Buy |
15,630
+1,010
| +7% | +$57K | 0.52% | 37 |
|
|
2014
Q3 | $748K | Sell |
14,620
-40
| -0.3% | -$2K | 0.44% | 47 |
|
|
2014
Q2 | $711K | Sell |
14,660
-2,110
| -13% | -$104K | 0.41% | 52 |
|
|
2014
Q1 | $871K | Sell |
16,770
-50
| -0.3% | -$2.66K | 0.53% | 37 |
|
|
2013
Q4 | $894K | Buy |
16,820
+319
| +2% | +$16.3K | 0.56% | 36 |
|
|
2013
Q3 | $764K | Buy |
16,501
+1,100
| +7% | +$48.3K | 0.55% | 38 |
|
|
2013
Q2 | $688K | Buy |
+15,401
| New | +$669K | 0.54% | 41 |
|
Other funds holding BMY
VCM
VPM
Bank of Stockton's BMY Position: Q1 2026 in Review
Bank of Stockton sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 4,306 shares — an estimated $232K sold.
Bank of Stockton first reported a position in BMY in Q2 2013 and held it in 51 quarters. The position peaked at $1.53M in Q2 2016. 2,526 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Bank of Stockton reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Bank of Stockton sold 4,306 Bristol-Myers Squibb shares in Q1 2026, an estimated $232K.
- Bank of Stockton first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 51 quarters.
- Bank of Stockton's Bristol-Myers Squibb position peaked at $1.53M in Q2 2016.
- 2,526 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Bank of Stockton's 13F filing for Q1 2026, filed 29 Apr 2026.